En Es
Categories

Industry News


Transasia Showcases Clinical Lab Solutions at APPI 2017

By Labmedica International staff writers
16 Jun 2017

Image: The Sysmex XN-330 hematology analyzer, one of three analyzers showcased at the APPI 2017 conference (Photo courtesy of Transasia).Transasia Bio-Medicals Ltd. (Mumbai, India), an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.

Transasia, a part of the global Erba Diagnostics Mannheim GmbH Group, offers solutions and products in biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. During the three-day event, which will be attended by over 1,000 practicing pathologists from India and across the world, the company will introduce new products and processes that provide an end-to-end solution for improved lab efficiency. Transasia will be introducing Sysmex XN-330, the latest six-part differential hematology analyzer as well as showcasing the EM 200, a fully automated biochemistry analyzer, and the ECL 760 coagulation analyzer.

Additionally, Transasia will also organize interactive scientific sessions and workshops led by experienced industry veterans in the fields of hematology, biochemistry and coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges, as well as open the doors for further discussions on the best practice approaches for addressing those challenges.



E-mail Print
FaceBook Twitter Google+ Linked in

ERBA MANNHEIM

Erba Diagnostics Mannheim, a company registered in Mannheim, Germany supplies Instruments, Reagents and Consumables conforming to IVD Directives.  It is a ISO 13485 : 2003 certified company. The requisite expertise and technical edge have made Erba “The Company of Choice” for supplying instruments under OEM labels for many diagnostic companies across Europe and Asia.
Gold member
More info

Additional news

17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More
16 Oct 2017
Release of X-Ray Database to Boost AI Research
The U.S. National Institutes of Health (NIH) recently made available a massive database of chest X-rays, marking a huge step toward integrating artificial intelligence (AI) mechanisms into clinical practice.
Read More
16 Oct 2017
BioVendor Acquires All Shares of DIAsource ImmunoAssays SA
BioVendor - Laboratornímedicínaa.s., an international diagnostics holding, has acquired 100% of the shares of DIAsourceImmunoAssays SA from Anteo Diagnostics, which had acquired DIAsource in January 2016.
Read More
16 Oct 2017
Handheld Scanners Market to Reach USD 725 Million by 2027
The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).
Read More
16 Oct 2017
Siemens Healthineers Enters Agreement with HORIBA Medical
Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally.
Read More
11 Oct 2017
Abbott Closes Acquisition of Alere
Abbott has closed the acquisition of Alere, Inc., following the receipt of all regulatory clearances required for the closing.
Read More
11 Oct 2017
Companies with Lab-Developed Tests Raise USD 2 Billion
Companies with laboratory-developed tests (LTDs), tests performed by laboratories owned by IVD companies and others, are attracting increasing investor interest and raised over USD 2 billion between January and August 2017. These are the latest findings of Kalorama Information, an independent medical market research firm.
Read More
10 Oct 2017
IBM Watson Uses AI to Determine Patients Who Need Contrast
Researchers at the University of California, San Francisco (UCSF) have discovered that IBM Watson can help optimize the process of determining which patients need contrast for musculoskeletal MRI scans.
Read More
10 Oct 2017
Toshiba to Change Name to Canon in January
Toshiba Medical Systems Corporation will change its company name to Canon Medical Systems Corporation on January 4, 2018. The decision by Toshiba Medical to change the company’s name comes after it officially became a subsidiary of Canon Inc. in December 2016.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions